multiply.jpg
 

SOBRE O PROJECTO

TESA , in its English acronym, is a consortium project established in 2009 through the collaborative effort of research institutes in Southern Africa and Universities involved in Clinical Trials. It is a network composed of different African and European research centers that collaborate with different levels of development and specialization, but with a complementary Clinical Research scenario. The project was also created as a mechanism to foster research collaboration through investment efforts on a joint path to a stronger and more sustainable clinical research landscape.

The TESA network has an overall strategic orientation aimed at creating a framework for collaboration, capacity building and training among consortium members and promoting healthy empowerment and personalized healthcare across the African region.

The TESA network has a proven track record in EDCTP-led Research and Development programs which have been established over the past decade among African and European countries that have participated since the first EDCTP programme.

Currently, the TESA project is in phase III in terms of implementation of the program financed by the EDCP, the former -

A eficácia do IPTi foi demonstrada em vários ensaios clínicos anteriores que comprovaram que é possível reduzir a malária em 30%, os internamentos hospitalares em 23% e a anemia em 21%. É também custo-efectivo, uma vez que o medicamento utilizado para o IPTi (sulfadoxina-pirimetamina, SP) é barato e que o IPTi utiliza um sistema de distribuição já existente, através do Programa Alargado de Vacinação (PAV). A Organização Mundial da Saúde (OMS) recomenda actualmente que sejam administradas 3 doses de IPTi às crianças no primeiro ano de vida, juntamente com as vacinas infantis, através do PAV.

TEAM

 

INSTITUIÇÕES ENVOLVIDAS

 
 

​ÚLTIMAS NOTÍCIAS